GO:0008236 serine-type peptidase activity: Mechanism, Genes and Research Methods

Research-grade guide for scientists and biopharma professionals

Key Takeaways

GO:0008236 (serine-type peptidase activity) describes catalysis of peptide-bond hydrolysis by a catalytic triad in which a serine nucleophile is activated by an acidic residue and a basic residue, usually histidine.
Serine-type peptidases are widespread across prokaryotes and eukaryotes and include degradative enzymes, processing proteases, and autoproteolytic proteins such as human lens betaA3-crystallin.
Activity-based protein profiling and quantitative metaproteomics have directly measured host and microbial serine-type endopeptidase activity in patient fecal samples, linking it to ulcerative colitis.
Bacterial penicillin-binding proteins (PBPs) are serine-type peptidases that remodel peptidoglycan; their activation by proteins such as LpoB and S protein is essential for cell wall synthesis and division.
Serine-type peptidase activity is also relevant to clinical biomarkers, as dipeptidyl peptidase 4 (DPP4) has been evaluated as a serum biomarker in rheumatoid arthritis.
CRISPR knockout, point-mutation, knock-in, and overexpression models allow causal testing of serine-type peptidase genes in cell and organoid systems.

Description

GO:0008236, serine-type peptidase activity, is a molecular function term describing enzymes that hydrolyze peptide bonds using a catalytic serine nucleophile. The reaction depends on a catalytic triad in which the serine hydroxyl is activated by a proton relay involving an acidic residue, such as aspartate or glutamate, and a basic residue, usually histidine. This mechanism is one of the best-characterized modes of proteolysis and is used by enzymes ranging from digestive proteases to bacterial cell-wall remodeling enzymes. The term is therefore central to understanding protein turnover, signaling, infection, and tissue remodeling. Researchers study serine-type peptidases because their activity can be measured directly in complex biological samples and because dysregulation is associated with human disease. For example, activity-based protein profiling and quantitative metaproteomics have identified host and microbial serine-type endopeptidase activity in fecal samples from patients with ulcerative colitis. In bacteria, serine-type peptidases such as penicillin-binding proteins are required for peptidoglycan synthesis and cell division, and their activation is tightly controlled by accessory proteins. In humans, proteins not traditionally classified as proteases, such as lens betaA3-crystallin, can display serine-type protease activity and undergo autodegradation. These examples show that GO:0008236 is not a single pathway but a mechanistic class of enzymes with broad biological and clinical relevance.

serine-type peptidase activity At A Glance

GO ID GO:0008236
GO term serine-type peptidase activity
Ontology molecular_function
Synonym serine protease activity
Definition Catalysis of the hydrolysis of peptide bonds in a polypeptide chain by a catalytic mechanism that involves a catalytic triad consisting of a serine nucleophile that is activated by a proton relay involving an acidic residue (e.g. aspartate or glutamate) and a basic residue (usually histidine).
Catalytic residues Serine nucleophile; acidic residue (Asp/Glu); basic residue (usually His)
Representative enzymes Penicillin-binding proteins, DPP4, lens betaA3-crystallin, and many microbial and host proteases
Related disease examples Ulcerative colitis, rheumatoid arthritis, bacterial cell-wall-related infection models

What Is GO:0008236?

In simple terms, serine-type peptidase activity means cutting a protein chain using a serine residue as the chemical knife. According to the QuickGO definition, this activity catalyzes the hydrolysis of peptide bonds in a polypeptide chain by a mechanism that involves a catalytic triad consisting of a serine nucleophile activated by a proton relay involving an acidic residue (e.g., aspartate or glutamate) and a basic residue (usually histidine). The synonym serine protease activity is often used. The defining features are the serine nucleophile and the acid-base relay, not the overall protein fold or biological context. Enzymes with this activity can act as endopeptidases or exopeptidases, can be processive or distributive, and can be regulated by zymogen activation, inhibitors, or allosteric partners.

Why Is serine-type peptidase activity Important in Cell Biology?

Serine-type peptidase activity matters because it controls protein fate and cell physiology across all domains of life. It contributes to protein degradation, activation of zymogens and signaling molecules, bacterial cell wall synthesis, and host-microbe interactions. The activity can be measured in patient samples, as shown by activity-based protein profiling of fecal microbiomes in ulcerative colitis, and it can serve as a disease biomarker, as illustrated by DPP4 in rheumatoid arthritis. Because the catalytic mechanism is conserved, mechanistic findings from bacterial enzymes such as penicillin-binding proteins and from human proteins such as lens betaA3-crystallin inform general principles of serine proteolysis. This makes GO:0008236 a high-value term for both basic and translational research.
Defines a major mechanistic class of proteolytic enzymes found in microbes, plants, and animals.
Underlies bacterial cell wall synthesis and division through penicillin-binding proteins and their activators.
Can be measured directly in complex clinical samples using activity-based protein profiling and metaproteomics.
Is linked to inflammatory disease activity, including ulcerative colitis and rheumatoid arthritis.
Includes autoproteolytic and non-canonical examples such as lens betaA3-crystallin autodegradation.
Provides targets for antibiotic and anti-inflammatory research, including beta-lactam and DPP4-related studies.
Supports functional genomics by enabling CRISPR-based tests of catalytic residues and regulatory partners.
Connects molecular mechanism to disease biomarkers and potential therapeutic intervention.

Molecular Mechanism of serine-type peptidase activity

Catalytic triad and serine nucleophile
In simple terms: A serine residue acts as the cutting tool, helped by two other residues.
The defining feature of GO:0008236 is a catalytic triad in which a serine hydroxyl acts as the nucleophile. The serine is activated by a proton relay that involves an acidic residue, typically aspartate or glutamate, and a basic residue, usually histidine. This arrangement lowers the pKa of the serine hydroxyl and enables nucleophilic attack on the carbonyl carbon of a peptide bond. The same mechanistic principle is used by diverse enzymes, including bacterial penicillin-binding proteins and human proteins such as lens betaA3-crystallin.
Substrate binding and peptide bond hydrolysis
In simple terms: The enzyme grabs a protein chain and breaks one peptide bond.
After substrate binding, the serine nucleophile attacks the scissile peptide bond, forming a covalent acyl-enzyme intermediate. The acidic and basic residues stabilize the transition state and facilitate deacylation by water. This mechanism allows serine-type peptidases to cleave polypeptide chains with varying specificity, from broad degradative proteases to highly selective processing enzymes. In bacterial cell wall synthesis, penicillin-binding proteins use this chemistry to cross-link peptidoglycan strands, and their activity is controlled by protein partners such as LpoB and S protein.
Allosteric activation and protein partners
In simple terms: Some serine peptidases need a partner protein to switch on.
Serine-type peptidase activity is not always constitutive. In Escherichia coli, LpoB transiently binds and activates PBP1b through a conserved allosteric switch, coupling cell wall synthesis to the division machinery. In Streptococcus pneumoniae, the S protein activates PBP1a to regulate peptidoglycan remodeling and cell division. PBP1b also fortifies the division site against osmotic rupture. These examples show that allosteric regulation and protein-protein interactions are integral to the biological output of serine-type peptidases.
Inhibition and clinical targeting
In simple terms: Many drugs and inhibitors work by blocking serine peptidases.
Because the catalytic serine is essential, serine-type peptidases are common drug targets. Beta-lactam antibiotics acylate penicillin-binding proteins, exploiting the same serine nucleophile that normally cross-links peptidoglycan. In human disease, DPP4 is a serine-type peptidase evaluated as a serum biomarker for disease activity and treatment response in rheumatoid arthritis. Activity-based probes can also report on active serine-type endopeptidases in complex samples, as demonstrated in fecal microbiome studies of ulcerative colitis.
Autoproteolysis and non-canonical serine proteases
In simple terms: Some proteins can cut themselves using serine-based chemistry.
Not all serine-type peptidases are dedicated proteases. Human lens betaA3-crystallin displays a serine-type protease activity that is responsible for its autodegradation. This finding broadens the functional scope of GO:0008236 and suggests that autoproteolytic events may contribute to protein turnover and cataract-related biology. Such non-canonical examples highlight the importance of experimental validation when annotating serine-type peptidase activity.

Key Genes Involved in GO:0008236 serine-type peptidase activity

The following genes and proteins are representative of serine-type peptidase activity and its regulation, based on the verified literature.
GeneMajor RoleResearch Relevance
PBP1b (E. coli mrcB)Penicillin-binding protein with serine-type peptidase activity; peptidoglycan cross-linking and division site integrityAllosteric activation by LpoB; osmotic rupture protection
PBP1a (S. pneumoniae)Penicillin-binding protein activated by S protein; peptidoglycan remodeling and cell divisionBacterial division and cell wall synthesis
LpoBOuter membrane lipoprotein that transiently binds and activates PBP1bAllosteric switch in cell wall synthesis
S protein (S. pneumoniae)Activator of PBP1aRegulation of peptidoglycan remodeling
DPP4Serine-type peptidase; serum biomarker in rheumatoid arthritisDisease activity and treatment response
BetaA3-crystallin (CRYBA3)Human lens protein with serine-type protease activity and autodegradationNon-canonical serine protease; lens biology
Beta-lactamase (representative)Serine-type enzyme that hydrolyzes beta-lactam antibioticsAntibiotic resistance mechanism
Microbial serine-type endopeptidasesHost and microbial proteolytic activity in gut microbiomeUlcerative colitis activity profiling
Host serine-type endopeptidasesProteolytic activity measured in fecal samplesHost-microbe interaction in ulcerative colitis
PBP1b partner proteinsAccessory factors for PBP1b functionCell division and osmotic stress
PBP1a partner proteinsAccessory factors for PBP1a functionCell wall remodeling
LpoB homologsConserved activators of PBPsComparative cell wall biology
Serine protease inhibitors (serpins)Regulate serine-type peptidase activityGeneral protease regulation (contextual)
Zymogen activation factorsConvert inactive precursors to active serine peptidasesProtease activation cascades (contextual)
Activity-based probes targetsActive serine-type endopeptidases in complex samplesMetaproteomics and clinical profiling
DPP4 substratesPeptides cleaved by DPP4Rheumatoid arthritis biomarker studies
Beta-lactam targetsPenicillin-binding proteinsAntibiotic mechanism

How Is serine-type peptidase activity Regulated?

Serine-type peptidase activity is regulated at multiple levels. In bacteria, allosteric activators such as LpoB and S protein control penicillin-binding protein function during cell wall synthesis and division. PBP1b also contributes to division site integrity under osmotic stress. In humans, serine-type peptidases can be regulated by zymogen activation, endogenous inhibitors, and autoproteolysis, as seen for lens betaA3-crystallin. Activity-based protein profiling can distinguish active from inactive enzymes in complex samples, providing a functional readout of regulation in disease states such as ulcerative colitis. DPP4 levels and activity are also monitored as a biomarker in rheumatoid arthritis.

serine-type peptidase activity and Human Disease

GeneDisease / BiologyPotential Experimental Model
Microbial and host serine-type endopeptidasesUlcerative colitisFecal metaproteomics and activity-based protein profiling
DPP4Rheumatoid arthritisSerum biomarker studies and enzyme activity assays
PBP1b (mrcB)Bacterial cell division and osmotic ruptureE. coli knockout and point-mutation models
PBP1a and S proteinPneumococcal cell wall remodelingS. pneumoniae knockout and activation assays
BetaA3-crystallinLens protein autodegradationRecombinant protein autodegradation assays
Inflammatory bowel disease and ulcerative colitis
Quantitative metaproteomics and activity-based protein profiling of patient fecal microbiome samples identified host and microbial serine-type endopeptidase activity associated with ulcerative colitis. This links GO:0008236 directly to an inflammatory disease context and suggests that measuring active serine-type peptidases could help characterize disease activity.
Rheumatoid arthritis and DPP4
Dipeptidyl peptidase 4 (DPP4), a serine-type peptidase, has been evaluated as a potential serum biomarker for disease activity and treatment response in rheumatoid arthritis. This illustrates how a serine-type peptidase can serve as a clinical biomarker and possible therapeutic target.
Bacterial infection and antibiotic resistance
Penicillin-binding proteins are serine-type peptidases essential for bacterial cell wall synthesis and division. Beta-lactam antibiotics target these enzymes, and beta-lactamases are serine-type enzymes that confer resistance. Therefore, GO:0008236 is central to antibacterial drug discovery and resistance mechanisms.
Lens biology and autoproteolysis
Human lens betaA3-crystallin exhibits serine-type protease activity responsible for its autodegradation. This non-canonical example connects GO:0008236 to protein stability in the lens and potentially to cataract-related processes, although further disease-specific studies are needed.

From serine-type peptidase activity-Related Genes to Experimental Models

Research QuestionSuitable Model
Is the catalytic serine required for substrate cleavage?Point mutation of the serine nucleophile (e.g., Ser-to-Ala)
Does loss of the gene affect cell wall synthesis or division?Knockout in bacteria such as E. coli or S. pneumoniae
Can a disease-associated variant alter activity?Knock-in of the variant and activity measurement
Where is the active enzyme localized?Tagged knock-in with fluorescent or affinity tag
Does overexpression increase proteolytic activity?Overexpression in cell lines or organoids
Can allosteric activators be identified?Knockout of partner proteins and rescue with point mutants

How to Study the serine-type peptidase activity Process

MethodWhat It MeasuresTypical Application
Activity-based protein profilingActive serine-type peptidases in complex samplesClinical microbiome and inflammation studies
Quantitative metaproteomicsProtein and peptide abundance in microbial communitiesHost-microbe interaction studies
Recombinant enzyme kineticsCatalytic activity and autodegradationMechanistic studies of purified proteins
Bacterial knockout and point mutationGene requirement and catalytic residue functionCell wall synthesis and division studies
Beta-lactam susceptibility testingSensitivity to antibiotics targeting PBPsAntibiotic resistance research
Serum biomarker assaysDPP4 levels or activityRheumatoid arthritis disease activity
Fluorescent tagging and imagingLocalization of active enzymesBacterial division site studies
CRISPR-based variant knock-inEffect of disease-associated variantsFunctional genomics of serine-type peptidases
Activity-based protein profiling
Activity-based protein profiling uses chemical probes that covalently label active serine-type peptidases, allowing direct measurement of enzyme activity in complex samples. This approach has been applied to fecal microbiome samples to identify host and microbial serine-type endopeptidase activity associated with ulcerative colitis.
Quantitative metaproteomics
Quantitative metaproteomics combines mass spectrometry with metagenomic data to quantify proteins and peptides in microbial communities. When paired with activity-based profiling, it can link specific serine-type peptidases to disease states such as ulcerative colitis.
Enzymatic assays with recombinant proteins
Recombinant expression and purification of candidate serine-type peptidases enables kinetic assays using peptide substrates. This approach was used to demonstrate the serine-type protease activity and autodegradation of human lens betaA3-crystallin.
Genetic and phenotypic assays in bacteria
Bacterial genetics, including knockout and point-mutation strains, can test the role of penicillin-binding proteins and their activators in cell wall synthesis, division, and osmotic stress resistance. Beta-lactam susceptibility assays can further probe serine-type peptidase function and resistance.

How CRISPR Can Be Used to Study GO:0008236 serine-type peptidase activity

Knockout

CRISPR knockout can delete a candidate serine-type peptidase gene to test its requirement in a biological process. For example, knocking out PBP1b or its activators in E. coli can reveal defects in cell division and osmotic stress resistance. In S. pneumoniae, knockout of PBP1a or S protein can disrupt peptidoglycan remodeling.

Point Mutation

Point mutation of the catalytic serine, acidic residue, or histidine in the catalytic triad can abolish serine-type peptidase activity while preserving protein expression. This strategy is useful for testing whether enzymatic activity is required for a phenotype, as demonstrated for autoproteolytic proteins such as lens betaA3-crystallin and for bacterial PBPs.

Knock-in

Knock-in of disease-associated variants or tagged versions of serine-type peptidase genes allows functional testing in a native context. Tagged knock-in can be used to localize active enzymes at division sites or other subcellular structures. Variant knock-in can test effects on activity and biomarker potential, as relevant to DPP4 in rheumatoid arthritis.

Overexpression

Overexpression of a serine-type peptidase can increase proteolytic activity and reveal downstream effects on substrates or cell physiology. This approach can be combined with activity-based probes or substrate profiling to identify targets, and it is applicable to microbial and host enzymes studied in disease contexts such as ulcerative colitis and rheumatoid arthritis.

How EDITGENE Supports serine-type peptidase activity Research

Researchers studying serine-type peptidase activity-related genes often need to determine whether a candidate gene is causally involved in a specific biological process or disease. CRISPR-based models provide a direct way to test gene function by deleting, mutating, tagging, or overexpressing the gene of interest. EDITGENE supports these studies with validated cell models and screening services tailored to serine-type peptidase research.
Contact EDITGENE today to design your custom CRISPR model for serine-type peptidase activity research.

Frequently Asked Questions About serine-type peptidase activity

Serine-type peptidase activity (GO:0008236) is the catalysis of peptide bond hydrolysis using a catalytic serine nucleophile activated by an acidic residue and a basic residue, usually histidine.
Representative genes and proteins include PBP1b, PBP1a, LpoB, S protein, DPP4, and betaA3-crystallin, as reported in the verified literature.
The GO ID is GO:0008236, and the synonym is serine protease activity.
It can be measured by activity-based protein profiling, quantitative metaproteomics, recombinant enzyme kinetics, and serum biomarker assays.
Yes, it has been associated with ulcerative colitis, rheumatoid arthritis, and bacterial cell wall-related infection processes.
The catalytic triad consists of a serine nucleophile, an acidic residue such as aspartate or glutamate, and a basic residue usually histidine.
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models can test the function of serine-type peptidase genes.
DPP4 has been evaluated as a serum biomarker for disease activity and treatment response in rheumatoid arthritis.
Bacteria use penicillin-binding proteins, which are serine-type peptidases, to synthesize and remodel peptidoglycan during cell wall synthesis and division.
Human lens betaA3-crystallin displays serine-type protease activity responsible for its autodegradation.

Conclusion

GO:0008236 serine-type peptidase activity is a fundamental molecular function that uses a catalytic triad to hydrolyze peptide bonds. Its biological importance spans bacterial cell wall synthesis, protein autodegradation, and human inflammatory disease, with direct evidence from metaproteomics, enzyme assays, and bacterial genetics. Studying this activity with CRISPR models and activity-based methods can reveal causal mechanisms and support biomarker or drug discovery efforts.

References

  1. 2. Gupta R et al.. 2010. A serine-type protease activity of human lens βA3-crystallin is responsible for its autodegradation.. Mol Vis 16:2242-52 PMID: 21139689
  2. 3. Shlosman I et al.. 2025. The hit-and-run of cell wall synthesis: LpoB transiently binds and activates PBP1b through a conserved allosteric switch.. Nat Commun 16(1):6723 PMID: 40691462
  3. 4. Pratt RF. 2016. β-Lactamases: Why and How.. J Med Chem 59(18):8207-20 PMID: 27232275
  4. 5. Thuy-Boun PS et al.. 2022. Quantitative Metaproteomics and Activity-based Protein Profiling of Patient Fecal Microbiome Identifies Host and Microbial Serine-type Endopeptidase Activity Associated With Ulcerative Colitis.. Mol Cell Proteomics 21(3):100197 PMID: 35033677
  5. 6. Millat H et al.. 2026. Streptococcus pneumoniae S protein activates PBP1a to regulate peptidoglycan remodelling and cell division.. Nat Microbiol 11(1):301-316 PMID: 41420061
  6. 7. Navarro PP et al.. 2026. The penicillin-binding protein PBP1b fortifies the Escherichia coli division site against osmotic rupture.. Nat Microbiol 11(8):2142-2156 PMID: 42399561
  7. 8. Yu J et al.. 2023. Dipeptidyl peptidase 4 as a potential serum biomarker for disease activity and treatment response in rheumatoid arthritis.. Int Immunopharmacol 119:110203 PMID: 37094543
Contact Us
*
*
*
*
How did you hear about us: